In vitro activity of various anthelmintic compounds against Haemonchus contortus larvae |
| |
| Authors: | RJ Boisvenue MC Brandt RB Galloway JC Hendrix |
| |
| Institution: | Parasitology Department, Lilly Research Laboratories, Division of Eli Lilly and Company, Greenfield, IN 46140 U.S.A. |
| |
| Abstract: | Twenty-five known anthelmintic compounds were evaluated in vitro against the highly motile exsheathed non-feeding third-stage of Haemonchus contortus larvae. Activity was based on lack of motility or death of larvae after 24 h of chemical exposure. Six compounds (avermectins, closantel, levamisole, morantel, phenylhydrazone and ticarbodine) were active at a concentration of 100 μg cm?3 or less. The most active compounds were avermectins and levamisole. When higher in vitro concentrations were used, ten compounds (bephenium, coumaphos, dichlorovos, disophenol, hygromycin b, methyridine, parbendazole, phenothiazine, pyrantel and thiabendazole) exhibited activity. Nine compounds were found to be inactive; among these were the new benzimidazoles, i.e., albendazole, fenbendazole, mebendazole and oxibendazole. Because of the inactivity of the new benzimidazoles, this in vitro system is unsuitable as a routine screening tool. Also, the system appears to favor drugs that act quickly through percuticular entry. In an initial group of 5280 untested compounds, 254 (4.8%) exhibited in vitro activity at 100 μg cm?3 against the non-feeding larvae stage. The exogenous and in vitro cultivation techniques required for collecting, cleaning and exsheating the larvae are described. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
